The prevalence of syncope increases with advancing age and is associated with significant morbidity and mortality. The diagnosis within this population can be complex due to atypical presentations, amnesia for events, absence of witnesses and the overlap with other clinical presentations, such as falls. The recently updated European Society of Cardiology guidelines on syncope propose structured assessment and management, which is also applicable to the older patient, with special attention to some additional features, pertinent to age-related comorbidity and frailty.
Introduction
Older patients frequently experience syncope. The diagnostic and therapeutic management may be complex in this group of age, particularly in the presence of other comorbidities or cognitive impairment. Morbidity related to syncope is more common in the elderly and ranges from loss of confidence, depressive illness and fear of falling, to fractures and consequent institutionalization. Moreover, advanced age is associated with short and long-term morbidity and mortality after syncope. 1 A standardized approach may obtain a definite diagnosis in more than 90% of the cases, may reduce diagnostic tests and rate of hospitalization. 2 The present article will review the characteristics of syncope in the elderly and will focus on initial evaluation and Emergency Department (ED) management, as proposed in the 2018 version of the European Society of Cardiology (ESC) guidelines on syncope. 1 Syncope is a transient loss of consciousness (TLOC) due to a transient global cerebral hypo-perfusion, characterized by a rapid onset, short duration, spontaneous and complete recovery. 1 TLOC is defined as a state of real or apparent LOC with loss of awareness, characterized by amnesia for the period of unconsciousness, abnormal motor control, loss of responsiveness, and a short duration. 1 There are two main groups of TLOC, those due to head trauma and non-traumatic TLOC. 1 A state that resembles prodromal symptoms of syncope, but which is not followed by LOC, is defined as pre-syncope. 1 
Epidemiology
Syncope is frequent in the general population 3 and is responsible for ED attendances and hospital admissions in 3% and 1% of the cases, respectively. 2 In the latest report of the Framingham Offspring study, 10% of the 7814 participants (mean age 51, range 20-96 years) reported at least one episode of syncope during a 17-years follow up. 3 The incidence rate of the first syncope was 6.2 per 1000 person years, with a sharp increase after 70 years from 5.7 events per 1000 person years in men aged 60 to 69 to 11.1 in men aged 70 to 79 -equivalent to an estimated 10 year cumulative incidence of 6%.
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Classification of syncope
Reflex syncope is the most frequent cause at all ages, 7 while orthostatic hypotension (OH) is a frequent cause of syncope in very old patients. 2 In the elderly, multiple causes are often present and the diagnosis within this population can be complex due to atypical presentations, amnesia for events, absence of witnesses and overlap with other clinical presentations, such as unexplained falls. 8 Therefore, an early and detailed assessment, through a standardized guideline-based approach, is mandatory. The principal causes of syncope are listed in Brignole et al. out triggers. Prodromal symptoms may be absent or short, and loss of consciousness may start abruptly, leading to collapse and injuries. 7 Nausea, blurred vision and diaphoresis are mostly common in VVS, whereas dyspnea is more predictive of cardiac syncope. 8 During the syncopal phase, myoclonic movements are rare in older subjects, probably because of a lack of asystolic response and a slower reduction in Systolic Blood Pressure (SBP). 9 A VVS which occurs upon standing may result in collapse, which can be misidentified as a fall, thereby rendering the clinical findings of these two conditions, very similar. In this context, retrograde amnesia was demonstrated in patients with syncope induced in a syncope clinic; indeed about 25% of patients fail to recall their prodromal symptoms and TLOC during tilt-induced syncope. 10 
Carotid sinus syncope
Carotid sinus hypersensitivity (CSH) can manifest as cardioinhibitory (CI-CSH) (asystole ≥3 seconds during Carotid Sinus Massage, CSM) or vasodepressor (a fall in SBP ≥50 mmHg during CSM) or mixed CSH and represents a positive response to CSM in an asymptomatic patient. 1 CSH could indicate an abnormal reflex, which may have a role in predisposing to unexplained falls. In this situation, syncope has to be considered, even if the typical sequence of a syncopal event cannot be recalled by the patient due to the presence of retrograde amnesia. Maggi et al. 11 showed that CI-CSH in patients with a clinical diagnosis of suspected neurallymediated syncope is related to a long asystolic reflex detected by an Implantable Loop Recorder at the time of the spontaneous syncope. When CSH occurs in a patient who has previously had syncope with reproduction of symptoms, this is defined as Carotid Sinus Syndrome (CSS). 1 The prevalence of CSS has been estimated to range from <4% in patients <40 years to 41% in those >80 years attending a specialized syncope facility. The related syncope has often little or no prodrome, with an increased risk of traumatic fall. Syncope recurrence is common and is reported to be 50% in 2 years. 12 The ESC guidelines on pacing 13 propose a 6 second cut-off for CSM-induced asystole, rather than the historical 3-second cut-off value, as the longer pause is more likely to be clinically relevant.
Moreover, several studies have demonstrated that isolated cardio-inhibitory response does not exist, since vasodepression is present in nearly all the patients, with variable intensity. 14 Therefore, a revision of conventional CSS classification has been proposed, considering CSS as a continuum between cardio-inhibition and vasodepression and including predominant cardio-inhibitory, predominant vasodepressor and mixed CSS. 15 This new interpretation can influence patient's referral for treatment, since cardiac pacing is less effective in the presence of a significant vasodepressor response, which may be responsible for syncopal recurrence.
Orthostatic hypotension
OH is defined as a fall in SBP from a baseline value ≥20 mmHg or diastolic BP ≥10 mmHg or a sustained decrease in systolic BP to an absolute value of <90 mmHg within 3 minutes of orthostatic position. 1 Since the magnitude of blood pressure drop also depends on baseline values, a drop of 30 mmHg might be a more appropriate criterion for OH in patients with supine hypertension. 15 OH increases with age, reaching 24.3% in the 8th decade and 30.9% in the 9th decade, 16 and has a prevalence of 12.4% in patients older than 65 years old consecutively referred to the ED for a TLOC. 17 The circulatory autonomic causes of orthostatic intolerance include initial orthostatic hypotension (IOH), classical orthostatic hypotension (COH), and delayed orthostatic hypotension (DOH). 1 IOH, which occurs within 15 seconds of standing, may have implications in older adults, particularly when on cardiovascular medications;
18 15% of long-term care residents indeed fall after rising to standing 19 and initial OH could potentially exacerbate this falling risk.
DOH is common in the elderly, due to impairment of compensatory reflexes and stiffer hearts, sensitive to a decrease in preload. 20 It may also represent a mild form of COH, especially if associated with Parkinsonism or diabetes. 21 Pharmacotherapy is the primary cause of OH in the older patient. A drug regimen based on alpha-receptor blockers, nitrates or benzodiazepines, was found to be a predictor of OH in this age group.
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Cardiac syncope
Cardiac causes of syncope are highly represented in the older population. 22 Short-lived syncope of abrupt onset and recovery, supine, during (rather than after) exercise or associated with palpitations or chest pain, should be considered cardiac until proven otherwise. A history of heart disease is an independent predictor of cardiac syncope with a sensitivity of 95% and specificity of 45%. 23 In particular, cardiac syncope should be suspected in patients with known or suspected left ventricular systolic dysfunction, valvular disease, left ventricular outflow tract obstruction, in those with an abnormal surface electrocardiogram (ECG) and where the clinical context and concomitant investigations suggest pulmonary embolism. A neurally-mediated cause of symptoms cannot be assumed in any patient with these clinical and diagnostic features until a cardiac cause has been effectively ruled-out.
Brady-and tachy-arrhythmias are the most common cardiac causes of cardiac syncope. Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults with a prevalence rising from 1 to 2% in the general population to nearly 5% in community dwelling people aged over 65 years old. 24 In a large cohort of community dwelling elderly patients, objectively diagnosed AF was associated with syncope, independent of stroke, cardiovascular drugs and other confounders. AF was also associated with one or more falls in the past year in those aged 65-74 years. 25 Guidelines 1 and clinical scoring systems 26, 27 for identifying high-risk patients include arrhythmias as a predictor of death and adverse events.
Multifactorial causes of syncope in older patients
Elderly patients often have multiple coexisting potential causes of syncope, and a definite diagnosis may be difficult. In a population of 873 consecutive patients older than 65 years, the rate of complex diagnoses [more than one diagnosis on an active standing test, Tilt Testing (TT) and CSM] was 23% and the most frequent association was between OH and VVS on TT in 15.8% of the cases. 16 In a sample of very old patients evaluated in a syncope and falls clinic, the most common causes of syncope in the elderly were OH/post-prandial hypotension, followed by cardiac disorders; while reflex syncope was less common. 28 It is therefore useful to complete a comprehensive evaluation, without stopping at the first diagnosis. 
Overlapping between syncope and falls
The incidence of syncope in older patients is likely to be higher than current estimates, due to the overlap with other presentations such as falls.
A fall is defined unexplained, when happens without accidental or clear medical conditions. 29 Unexplained falls represent a common cause of hospital admission and are associated with increased healthcare costs. 30 Especially in older adults in whom the circumstances of a fall are unclear, because of the lack of witnesses and amnesia for the episode, a misdiagnosed syncope may underlie an unexplained fall. About 20% of cardiovascular syncope in patients older than 70 years old presents as a fall, especially in patients with CSS and OH. More than 20% of the older patients with CSS complain of falls as well as syncope. 31 In patients older than 60 years admitted to the hospital because of a fall or syncope, fallers who had CSS during CSM, showed retrograde amnesia for the loss of consciousness, more frequently than patients with syncope. 32 Furthermore, over one third of the falls in patients in orthopedic wards are unexplained, particularly in those with depressive symptoms and syncopal spells, 33 underscoring the importance of a comprehensive clinical history and assessment at the very beginning of the medical pathway.
Those unexplained falls, initially considered as not being due to an episode of syncope, but in which a final diagnosis of syncope is confirmed after a diagnostic work-up, have been recently defined as syncopal falls. 34 Falls can result from a postural drop in BP. Two to ten % of the falls in older adults may occur secondary to impaired hemodynamic responses and loss of consciousness is estimated to result in as many as 10% of falls. 35 In many cases, loss of consciousness is avoided, but increased susceptibility to falling remains through pre-syncope and associated physiological impairments. 36 Impaired orthostatic BP recovery, delayed recovery or sustained OH are independent risk factors for future falls, unexplained falls, and injurious falls. 37 
Initial evaluation
The initial evaluation, which consists of clinical history, physical examination, an active standing test and a 12-lead ECG, should answer some key questions: 1 
i) Was the event TLOC? ii) In the case of TLOC, is it of syncopal or non-syncopal origin? iii) In suspected syncope, is there a clear aetiological diagnosis? iv) Is there evidence to suggest a high risk of cardiovascular events or death?
Brignole et al. 1 outlined the steps for initial evaluation and risk stratification of patients with syncope.
The clinical history should include the collection of comorbidities, physical frailty and loco-motor disabilities, details of cognitive status, social circumstances, injuries, impact of the event on functional capacity. Eyewitness accounts should be collected, given the frequent presence of retrograde amnesia in the elderly. Particular attention should be paid to the time of the day, season, relationship with meals, micturition, body position, drugs, length of treatment and time-relationship between drug consumption and appearance of adverse effects. 1 Precise details of the drug regimen have to be collected as numerous drugs, e.g., alpha-receptor blockers, nitrates or benzodiazepines, were found to be predictors of OH. Attention should be paid to reappraisal of the drug regimen in the presence of OH, in order to reduce the recurrence of syncope. 16 A comprehensive physical examination, extended to include vision, cognitive status, gait, standing balance and evaluation of the loco-motor system including the feet, to assess risk factors for falls is suggested.
The active standing test consists of the measurement of BP in the supine position, immediately upon standing and after 1 to 3 minutes of standing. Given the age-related increase in OH, standing BP measurements are mandatory in the elderly and should be repeated, preferably in the morning and/or promptly after the syncope, as the standing fall in BP is not always reproducible, especially when related to drugs or predisposing conditions. 1 The 12-lead ECG is diagnostic, can remove the need for further cardiac evaluation and permits institution of treatment, in cases of: i) persistent sinus bradycardia <40 bpm in awake or repetitive sinus-atrial block or sinus pauses >3 s; ii) Mobitz II 2nd or 3rd degree atrio-ventricular block, alternating left and right bundle branch block; iii) ventricular tachycardia (VT) or rapid paroxysmal supra-ventricular tachycardia; iv) non sustained episodes of polymorphic VT and long or short QT interval; v) acute ischemia with or without myocardial infarction. 1 However, studies have shown that an ECG will determine the cause of syncope in only 5% of patients. 38 The ESC guidelines on syncope 1 propose the execution of CSM on the initial evaluation in patients aged >40 years. The test is performed under continuous HR and beat-to-beat BP monitoring, for 10 seconds, bilaterally, first in the supine and then in the upright position, on TT at an angle of 60°. The added diagnostic value of repeating CSM in the upright position has been documented. 39 To assess the contribution of the vasodepressive component, CSM may be repeated after intravenous administration of 0.02 mg/Kg of atropine, which eliminates vagally-induced asystole, thereby unmasking vasodepression. 40 This quantification of the vasodepressive component is clinically relevant, because it has been shown that pacemaker therapy is less effective when the vasodepressive effect is large, compared with predominant cardioinhibition. 41 CSM should be undertaken with caution in patients with previous transient ischemic attack, stroke, or known carotid stenosis >70%. 1 Additional tests may be performed: immediate ECG monitoring in suspected arrhythmic syncope; echocardiogram in known heart disease, or syncope secondary to cardiovascular cause; TT when there is suspicion of syncope due to OH or reflex syncope. Blood tests, e.g. haematocrit or haemoglobin when haemorrhage is suspected, oxygen saturation and blood gas analysis when hypoxia is suspected, troponin when cardiac ischaemia-related syncope is suspected, or D-dimer when pulmonary embolism is suspected, etc. 1 In case of certain or highly likely diagnosis after the initial evaluation, no further evaluation is needed, and definitive treatment can be planned.
Emergency department management of syncope based on risk stratification
The ED management of TLOC of suspected syncopal nature should follow the three following main steps.
Identify serious underlying causes of syncope
The primary aim of an ED physician is to detect and treat acute underlying diseases, which most frequently determine short-term adverse events, rather than the syncope itself. This is particularly relevant in the older patient who often has comorbidities and more than one possible cause of syncope. The presence of a cardiovascular diagnosis, such as aortic stenosis or atrial fibrillation in this age group, may be coincidental rather than the attributable cause of events.
Establish the risk of a serious outcome
The second step is to distinguish between patients with lowand high-risk conditions; patients at low-risk should be discharged with adequate education but high-risk patients need hospital admission and urgent full investigation. While low-risk patients are more likely to have reflex syncope and an excellent prognosis, high-risk ones are more likely to have cardiac syncope and a worse prognosis. Structural heart disease and cardiac arrhythmias are major risk factors for sudden cardiac death and overall mortality in patients with syncope. 42, 43 Features that suggest low and high risk conditions are listed in Brignole et al. 
Choose between discharge and hospital admission
The rate of hospital admission for syncope, after the evaluation in the ED varies between 12 and 86%. The main aim of ED physicians is to identify high-risk patients, needing early investigations and hospitalization, while unnecessary admission in low-risk patients can be harmful.
The implementation of organizational approaches, such as ED Observation Units and Syncope Clinics, offers safe and effective alternatives to admission in some cases. 1 Several risk stratification tools have been validated, none of which are widely used in EDs, due to poor sensitivity and specificity. 1 Risk stratification tools perform no better than clinician judgment at predicting short-term serious outcomes.
43
Conclusions
The diagnostic protocol proposed by the ESC guidelines on syncope, 1 is applicable at any age, but some additional features, pertinent to age-related comorbidity and frailty, warrant special attention. Comorbidity influences the diagnosis of syncope and management decisions, so a comprehensive, multifactorial evaluation extended to include cognitive assessment, physical performance and functional assessment, is recommended. Intervention is often multi-faceted. As the risk of syncope and falls is increased by polypharmacy, a careful revision of the drug regimen is essential. Unexplained falls should be evaluated as for unexplained syncope. 
